1. Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. Issue 8 (August 2018) Authors: Schlumberger, Martin; Leboulleux, Sophie; Catargi, Bogdan; Deandreis, Desiree; Zerdoud, Slimane; Bardet, Stephane; Rusu, Daniela; Godbert, Yann; Buffet, Camille; Schvartz, Claire; Vera, Pierre; Morel, Olivier; Benisvy, Danielle; Bournaud, Claire; Toubert, Marie-Elisabeth; Kelly, Antony; Benhamou,... Journal: Lancet Issue: Volume 6:Issue 8(2018) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗